Zura Bio (ZURA)

• Market cap: $395M
• 1 day: -2.09%
• 5 days: -4.25%
• 1 month: 17.83%
• 3 months: 45.45%
• 6 months: 282.39%
• Year to date: 9.55%
• 1 year: 305.33%
• 5 years: -37.32%
• 10 years: -37.32%
• Sector: Healthcare
• Industry: Biotechnology

About: Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Employees: 30